Collegium Pharmaceutical (COLL) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -58.34% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -14.91% |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn | 42.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.46% |
| Dec 31, 2025 | 87.20% |
| Sep 30, 2025 | 78.21% |
| Jun 30, 2025 | -87.35% |
| Mar 31, 2025 | -91.60% |
| Dec 31, 2024 | -47.42% |
| Sep 30, 2024 | -82.36% |
| Jun 30, 2024 | 86.86% |
| Mar 31, 2024 | 146.42% |
| Dec 31, 2023 | 459.91% |
| Sep 30, 2023 | 779.27% |
| Jun 30, 2023 | 1,118.05% |
| Mar 31, 2023 | 1,076.90% |
| Dec 31, 2022 | 107.97% |
| Sep 30, 2022 | -85.31% |
| Jun 30, 2022 | -85.37% |
| Mar 31, 2022 | -103.19% |
| Dec 31, 2021 | -470.08% |
| Sep 30, 2021 | 474.26% |
| Jun 30, 2021 | 271.32% |